Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents

作     者：Ying Shen Wei-Feng Shen 

作者机构：Department of Cardiology Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200025 China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2015年第128卷第6期

页      面：711-713页

核心收录：

学科分类：10[医学] 

主　　题：Dual Antiplatelet Therapy Percutaneous Coronary Intervention Drug-eluting Coronary Stents 

摘      要：Percutaneous coronary intervention （PCI） with implantation of drug-eluting stents （DESs） has become the standard of care for coronary artery disease and gives a great impetus to device industry. In 2013, approximately half million patients with coronary artery disease underwent PCI in China with a penetration rate of DES reaching beyond 95%.131 The use of DES including domestic ones is highly effective in preventing coronary restenosis, but there is a collateral cost to be borne in terms of delayed healing or re-endothelialization of the stented arterial segment and risk of stent thrombosisJ41 Therefore.